Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Altruline

    Client Email Product

    Altruline

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    64
    US DMFs Filed

    US DMFs Filed

    24
    CEP/COS Certifications

    CEP/COS Certifications

    21
    JDMFs Filed

    JDMFs Filed

    7
    Other Certificates

    Other Certificates

    22
    Other Suppliers

    Other Suppliers

    31
    API REF. PRICE (USD / KG)
    127

    API Market Place

    17
    INTERMEDIATES
    15
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    96
    Europe

    Europe

    216
    Canada

    Canada

    51
    Australia

    Australia

    34
    South Africa

    South Africa

    25
    Uploaded Dossiers

    Uploaded Dossiers

    46
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,162.00

    Annual Reports

    299.00

    FDF Market Place

    6
    EXCIPIENTS
    235
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    28
    REF STANDARD

    EDQM

    4

    USP

    3

    JP

    0

    Other Listed Suppliers

    11
    SERVICES

    0

    left grey arrow
    right gray arrow
    • TABLET;ORAL - EQ 100MG BASE
    • TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - EQ 25MG BASE
    • TABLET;ORAL - EQ 50MG BASE
    Full View ScreenFull Screen View
    An Indian industrialist wants to buy Biogaran, the French number one in generics
    An Indian industrialist wants to buy Biogaran, the French number one in generics

    https://www.20minutes.fr/economie/4087038-20240418-biogaran-poids-lourd-francais-medicaments-generiques-vendu-groupe-etranger

    20MINUTES
    18 Apr 2024
    Share Share
    Health Canada Issues Recall of Sivem Pharmaceuticals's Quetiapine
    Health Canada Issues Recall of Sivem Pharmaceuticals's Quetiapine

    https://recalls-rappels.canada.ca/en/alert-recall/quetiapine-25-mg-affected-lot-quetiapine-25-mg-may-contain-sertraline-50-mg-tablets

    HEALTH CANADA
    09 Sep 2022
    Share Share
    Booster shot improves immunity; post-COVID depression helped by drugs
    Booster shot improves immunity; post-COVID depression helped by drugs

    https://www.reuters.com/article/us-health-coronavirus-science/booster-shot-improves-immune-response-of-chemotherapy-patients-post-covid-depression-helped-by-widely-used-drugs-idUSKBN2GW282

    Nancy Lapid REUTERS
    06 Oct 2021
    Share Share
    Ascentage Pharma`s Generic Sertraline Hydrochloride Receives Approval In US
    Ascentage Pharma`s Generic Sertraline Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214790

    FDA
    06 May 2021
    Share Share
    Proveris Scientific Expands its Laboratory Services Team
    Proveris Scientific Expands its Laboratory Services Team

    https://www.proveris.com/2020/08/11/proveris-scientific-expands-its-laboratory-services-team/

    PRESS RELEASE
    11 Aug 2020
    Share Share
    FDA data shows numerous drugs in shortage, including a leading antidepressant
    FDA data shows numerous drugs in shortage, including a leading antidepressant

    https://www.usatoday.com/story/news/2020/06/10/coronavirus-and-fda-drug-shortage-list/5330491002/

    Dian Zhang USATODAY
    12 Jun 2020
    Share Share
    Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19
    Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19

    https://www.fiercepharma.com/pharma/drugmakers-struggle-to-meet-demand-for-antidepressant-zoloft-amid-covid-19

    E. Sagonowsky FIERCE PHARMA
    03 Jun 2020
    Share Share
    Antidepressant Zoloft falls into shortage due to anxiety around COVID-19
    Antidepressant Zoloft falls into shortage due to anxiety around COVID-19

    http://www.pharmafile.com/news/550253/antidepressant-zoloft-falls-shortage-due-anxiety-around-covid-19

    PHARMAFILE
    01 Jun 2020
    Share Share
    Sertraline improves anxiety, but ‘unlikely’ to treat depression
    Sertraline improves anxiety, but ‘unlikely’ to treat depression

    http://www.pharmatimes.com/news/sertraline_improves_anxiety,_but_unlikely_to_treat_depression_1302118

    Anna Smith PHARMATIMES
    20 Sep 2019
    Share Share
    Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
    Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial

    https://www.fiercebiotech.com/biotech/lundbeck-and-otuska-s-brexpiprazole-hits-mark-ptsd-trial

    Nick P Taylor FIERCE BIOTECH
    01 Dec 2018
    Share Share
    Lundbeck’s Dunsire has something to cheer as Rexulti combo shows promise in PTSD
    Lundbeck’s Dunsire has something to cheer as Rexulti combo shows promise in PTSD

    https://endpts.com/lundbecks-dunsire-has-something-to-cheer-as-rexulti-combo-shows-promise-in-ptsd/

    ENDPTS
    30 Nov 2018
    Share Share
    How pharma and healthcare shifted strategies post-blockbuster drug success
    How pharma and healthcare shifted strategies post-blockbuster drug success

    http://www.mmm-online.com/agencies/how-pharma-healthcare-shifted-strategies-post-blockbuster-drug-success/article/762751/

    ONLINE
    04 May 2018
    Share Share
    Antidepressant-Migraine Drug Combination Found Less Risky Than Believed
    Antidepressant-Migraine Drug Combination Found Less Risky Than Believed

    https://www.forbes.com/sites/davidkroll/2018/02/28/antidepressant-migraine-drug-combination-found-less-risky-than-believed/#4b631c8e3496

    David Kroll FORBES
    28 Feb 2018
    Share Share
    Enforcement Report - Week of January 10, 2018
    Enforcement Report - Week of January 10, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-10-2018-1515560737.pdf

    FDA
    10 Jan 2018
    Share Share
    Pfizer defeats appeals over Zoloft birth defects
    Pfizer defeats appeals over Zoloft birth defects

    http://www.nasdaq.com/article/pfizer-defeats-appeals-over-zoloft-birth-defects-20170602-00473

    NASDAQ
    03 Jun 2017
    Share Share
    Pa. Court Upholds Pfizer Win In Zoloft Birth Defect Suit
    Pa. Court Upholds Pfizer Win In Zoloft Birth Defect Suit

    https://www.law360.com/lifesciences/articles/921696

    Dan Packel LAW360
    09 May 2017
    Share Share
    Sivem Pharmaceuticals ULC Recalls Sertraline Capsules
    Sivem Pharmaceuticals ULC Recalls Sertraline Capsules

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/61850r-eng.php

    HEALTH CANADA
    17 Jan 2017
    Share Share
    Apotex Inc. Voluntary Recalls Apo-Sertraline
    Apotex Inc. Voluntary Recalls Apo-Sertraline

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/61808r-eng.php

    HEALTH CANADA
    16 Jan 2017
    Share Share
    Pfizer beats hundreds of lawsuits alleging Zoloft birth defects
    Pfizer beats hundreds of lawsuits alleging Zoloft birth defects

    http://www.reuters.com/article/us-pfizer-lawsuit-zoloft-idUSKCN0X31PU

    Jessica Dye REUTERS
    07 Apr 2016
    Share Share
    Will Gilead Follow The Pfizer Game Plan For Sales Growth?
    Will Gilead Follow The Pfizer Game Plan For Sales Growth?

    http://www.forbes.com/sites/johnlamattina/2016/02/02/will-gilead-follow-the-pfizer-game-plan-for-sales-growth/?ss=pharma-healthcare#76f8d94819e0

    John LaMattina FORBES
    03 Feb 2016
    Share Share
    Daiichi to launch new generic drugs today through its Espha subsidiary
    Daiichi to launch new generic drugs today through its Espha subsidiary

    http://www.pharmabiz.com/NewsDetails.aspx?aid=92182&sid=2

    PHARMABIZ
    10 Dec 2015
    Share Share
    Pfizer turns aside yet another case alleging Zoloft caused birth defects
    Pfizer turns aside yet another case alleging Zoloft caused birth defects

    http://www.fiercepharma.com/story/pfizer-turns-aside-yet-another-case-alleging-zoloft-caused-birth-defects/2015-10-09

    Eric Palmer FIERCE PHARMA
    09 Oct 2015
    Share Share
    UPDATED: FDA asks Pfizer for Zoloft label update highlighting birth defect risks
    UPDATED: FDA asks Pfizer for Zoloft label update highlighting birth defect risks

    http://www.fiercepharma.com/story/fda-asks-pfizer-zoloft-label-update-highlighting-birth-defect-risks/2015-09-18

    Emily Wasserman FIERCE PHARMA
    19 Sep 2015
    Share Share
    Zoloft Plaintiffs Seek Pfizer Expert's Ex Parte Messages
    Zoloft Plaintiffs Seek Pfizer Expert's Ex Parte Messages

    http://www.thelegalintelligencer.com/id=1202732109500/Zoloft-Plaintiffs-Seek-Pfizer-Experts-Ex-Parte-Messages?mcode=1202615580822

    P.J. D\'Annunzio THE LEGAL INTELLIGENCER
    15 Jul 2015
    Share Share
    Pfizer Report Warns of Possible Zoloft and Birth Defect Link
    Pfizer Report Warns of Possible Zoloft and Birth Defect Link

    http://finance.yahoo.com/news/pfizer-report-discloses-potential-zoloft-180128436.html

    Jef Feeley YAHOO FINANCE
    10 Jun 2015
    Share Share
    Antidepressant and Heart Drug Show Promise for Combating Ebola
    Antidepressant and Heart Drug Show Promise for Combating Ebola

    http://www.scientificamerican.com/article/antidepressant-and-heart-drug-show-promise-for-combating-ebola/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciam%2Fhealth-and-medicine+%28Topic%3A+Health%29

    Rachael Rettner And LiveScience SCIENTIFIC AMERICAN
    03 Jun 2015
    Share Share
    Pfizer Accused of Knowing Zoloft Posed Birth-Defect Risk
    Pfizer Accused of Knowing Zoloft Posed Birth-Defect Risk

    http://www.bloomberg.com/news/articles/2015-04-09/pfizer-assailed-at-opening-of-zoloft-birth-defect-risk-trial

    Jef Feeley BLOOMBERG BUSINESS
    13 Apr 2015
    Share Share
    Antidepressants Have Sexual Side Effects In Teens, Too
    Antidepressants Have Sexual Side Effects In Teens, Too

    http://uk.reuters.com/article/2015/03/23/us-antidepressants-teens-side-effects-idUKKBN0MJ24C20150323

    Lisa Rapaport REUTERS
    25 Mar 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search